Literature DB >> 6155475

Monoclonal antibodies identify individual determinants on mouse mammary tumor virus glycoprotein gp52 with group, class, or type specificity.

R J Massey, L O Arthur, R C Nowinski, G Schochetman.   

Abstract

Hybrid cell lines producing monoclonal antibodies against the C3H strain of mouse mammary tumor virus (C3H MMTV) were prepared by the fusion of mouse myeloma cells with the lymphocytes of BALB/c mice that were immunized with C3H MMTV. Approximately 10% of the hybrid cells initially plated after cell fusion produced immunoglobulins that reacted in antibody-binding assays with C3H MMTV; 40 of these cells were cloned, and 6 eventually yielded stable cell lines. High concentrations of monoclonal antibodies (5 to 20 mg/ml) were obtained from serum and ascites fluid of syngeneic mice inoculated with the hybrid cells. All of the monoclonal antibodies were directed against the envelope glycoprotein gp52. Three of the hybrid cell lines produced immunoglobulins of the immunoglobulin M subclass and three produced immunoglobulin G2a. The monoclonal antibodies showed limited charge heterogeneity in light and heavy chains when analyzed by high-resolution, two-dimensional gel electrophoresis. Three serologically distinct specificities were observed when these ascites fluids were tested against different strains of MMTV. The antigenic determinants detected were the following: (i) a type-specific determinant unique to the C3H strain of MMTV; (ii) class-specific determinants shared between C3H and GR MMTVs; and (iii) a group-specific determinant found on C3H, GR, RIII, and the endogenous C3H (C3Hf) MMTVs. Because monoclonal antibodies recognize single antigenic determinants, these results demonstrate for the first time that the three patterns of antigenic reactivity for MMTV are related to individual determinants on the gp52 molecule and also clearly show that one strain of MMTV can be distinguished from other strains.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6155475      PMCID: PMC288751          DOI: 10.1128/JVI.34.3.635-643.1980

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

3.  Tissue culture studies of mouse mammary tumor cells and associated viruses.

Authors:  R B Owens; A J Hackett
Journal:  J Natl Cancer Inst       Date:  1972-11       Impact factor: 13.506

4.  Structural proteins of mammalian oncogenic RNA viruses: multiple antigenic determinants of the major internal protein and envelope glycoprotein.

Authors:  M Strand; J T August
Journal:  J Virol       Date:  1974-01       Impact factor: 5.103

5.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Autogenous immunity to mouse mammary tumor virus in mouse strains of high and low mammary tumor incidence.

Authors:  J N Ihle; L O Arthur; D L Fine
Journal:  Cancer Res       Date:  1976-08       Impact factor: 12.701

8.  Induction of GIX antigen and gross cell surface antigen after infection by ecotropic and xenotropic murine leukemia viruses in vitro.

Authors:  P V O'Donnell; E Stockert
Journal:  J Virol       Date:  1976-12       Impact factor: 5.103

9.  In vitro system for production of mouse mammary tumor virus.

Authors:  D L Fine; L O Arthur; J K PLOWMAN; E A Hillman; F Klein
Journal:  Appl Microbiol       Date:  1974-12

10.  Antigens of leukemias induced by naturally occurring murine leukemia virus: their relation to the antigens of gross virus and other murine leukemia viruses.

Authors:  G Geering; L J Old; E A Boyse
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Monoclonal antibodies against microorganisms.

Authors:  R A Polin
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

Review 2.  Hybridomas: a new dimension in biological analyses.

Authors:  R H Kennett
Journal:  In Vitro       Date:  1981-12

3.  Monoclonal antibodies against baboon endogenous virus and against host cell antigens.

Authors:  J Cogniaux; R Olislager; S Sprecher-Goldberger; L Thiry
Journal:  J Virol       Date:  1982-08       Impact factor: 5.103

4.  Processing and amino acid sequence analysis of the mouse mammary tumor virus env gene product.

Authors:  L O Arthur; T D Copeland; S Oroszlan; G Schochetman
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

5.  Distribution of mouse mammary tumor virus in Asian wild mice.

Authors:  S Imai; M Okumoto; M Iwai; S Haga; N Mori; N Miyashita; K Moriwaki; J Hilgers; N H Sarkar
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

6.  The endogenous proviral mouse mammary tumor virus genes of the GR mouse are not identical and only one corresponds to the exogenous virus.

Authors:  P Herrlich; N E Hynes; H Ponta; U Rahmsdorf; N Kennedy; B Groner
Journal:  Nucleic Acids Res       Date:  1981-10-10       Impact factor: 16.971

7.  Monoclonal antibodies against antigens displayed on a progressively growing mammary tumor.

Authors:  A Tax; L A Manson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

8.  Late developing mammary tumors and hyperplasia induced by a low-oncogenic variant of mouse mammary tumor virus (MMTV) express genes identical to those induced by canonical MMTV.

Authors:  Robert D Bruno; Sonia M Rosenfield; Gilbert H Smith
Journal:  Mol Cancer       Date:  2013-07-18       Impact factor: 27.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.